Berkery Noyes announced today that the firm represented BG Media Investors on the sale of its portfolio company HMP Communications (âHMPâ) to Paul Mackler, Ken Fisher, and Alta Communications. Terms of the transaction, were not disclosed.
HMP, launched in 1985, has grown significantly over the past two decades to become the premier resource for medical information and education in select therapeutic fields. Today, HMP Communications reaches tens of thousands of healthcare professionals providing medical information, groundbreaking research and continuing medical education through its journals, newsletters, books, CDâs, meetings, conferences, exhibitions, symposia, and online.
âThis is an excellent match with Alta Communications backing seasoned information veterans with a winning healthcare and information franchise.â said Tom OâConnor, the Berkery Noyes Managing Director who managed the transaction on behalf of BG Media Investors
Paul Mackler, who will assume the role of HMP President & CEO said, âWe are very pleased to be partnering with Peter Norris, executive vice president of HMP and the existing management team given how well they have built the company. We intend to pursue strategic bolt-on acquisitions that will enhance and strengthen the companyâs position in each market served, enabling HMP to expand its products and services to its valued customers and clients.â
âHealthcare is an industry that touches everyone,â HMPâs Executive Vice President Peter Norris said. âInsuring that our caregivers have access to the most complete clinical information within their field of expertise is crucial. The HMP staff and contributing medical professionals that are responsible for generating relevant information distributed through HMP Communications are outstanding. This acquisition is an investment in our media as well as the people that make them successful.â
Berkery Noyes acted as exclusive financial advisor to BG Media Investors on the sale of HMP Communications. Berkery Noyes has been involved with many of the most notable transactions in the healthcare, pharmaceutical tools and services, and medical marketing sectors involving both strategic and financial buyers and sellers.